Gene · 79813
NIH grants1,962
NIH grants whose papers are about the gene, through NIH's grant-paper links.
541 to 560 of 1,962
Download this page as JSON| Grant | Title | EHMT1 papers | Newest fiscal year |
|---|---|---|---|
| P01CA193124 | Processing and Repair of DNA Crosslinks | 2 | 2022 |
| R01CA078831 | Epigenetic regulation by tumor suppressor p53 | 2 | 2022 |
| R01CA222871 | A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass. | 2 | 2022 |
| R01CA227433 | TUMOR SPECIFIC DELIVERY OF VERTICILLIN A OVERCOMES EPIGENETIC SILENCING RESPONSIBLE FOR DRUG RESISTANCE | 2 | 2022 |
| R01HL121197 | LncRNA mechanism of heart failure | 2 | 2022 |
| R01MH096066 | Novel epigenetic mechanisms in neuronal development and cognitive function | 2 | 2022 |
| R37GM059785 | Molecular mechanisms of histone modification | 2 | 2022 |
| R37GM062437 | Protein Acylation and Methylation Mechanisms | 2 | 2022 |
| U01DK098246 | Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study | 2 | 2022 |
| UL1TR002489 | North Carolina Translational and Clinical Science Institute (NC TraCS) | 2 | 2022 |
| UL1TR002529 | Indiana Clinical and Translational Sciences Institute | 2 | 2022 |
| UL1TR002649 | Center for Clinical and Translational Research | 2 | 2022 |
| I01BX004031 | Promoting metabolic health through the reduction of dietary branched chain amino acids | 1 | 2022 |
| K01HL140271 | The role of epigenetic transcriptional memory in monocyte-macrophage cells and cardiovascular disease risk | 1 | 2022 |
| K02ES029119 | New Mechanism of Arsenic Carcinogenesis | 1 | 2022 |
| K08CA222684 | Targeting mitochondrial one carbon folate metabolism for novel T-cell acute lymphoblastic leukemia therapy | 1 | 2022 |
| K08CA232344 | Development of a surrogate liquid biopsy from the aqueous humor in retinoblastoma eyes. | 1 | 2022 |
| K23AR075099 | Volumetric bone density, geometry, strength and bone tissue material properties in type 1 diabetes | 1 | 2022 |
| K23DK114460 | Mechanisms of Enteroendocrine L-Cell Dysfunction and Bile Adaptations to Weight Loss | 1 | 2022 |
| K99DK127196 | Genetically harmonized dietary intake and causal relationships with diabetes-related outcomes | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79813/grants?page=28